17 GLP-1 drugs are effective for weight management, including in perimenopausal women, based on general population data, she explains
In a phase 1 trial, a PYY analogue (Y14 peptide) administered subcutaneously at 7- to 14-days intervals was safe and potentially efficacious (WL between 2.9 and 3.6 kg at 31 days, with a 3855% reduction in food intake vs
This reduction may influence extracellular matrix remodeling, immune cell recruitment, and paracrine signaling in surrounding tissues
In addition to dietary choices, engaging in regular physical activity is essential for optimizing GLP-1 secretion
Centers for Medicare & Medicaid Services
Loren says that when she first started a GLP-1, even the smell of coffee made her nauseous